Show simple item record

dc.contributor.authorThiyagarajan, Durairaj
dc.contributor.authorHuck, Benedikt
dc.contributor.authorNothdurft, Birgit
dc.contributor.authorKoch, Marcus
dc.contributor.authorRudolph, David
dc.contributor.authorRutschmann, Mark
dc.contributor.authorFeldmann, Claus
dc.contributor.authorHozsa, Constantin
dc.contributor.authorFurch, Marcus
dc.contributor.authorBesecke, Karen F W
dc.contributor.authorGieseler, Robert K
dc.contributor.authorLoretz, Brigitta
dc.contributor.authorLehr, Claus Michael
dc.date.accessioned2021-07-01T13:34:57Z
dc.date.available2021-07-01T13:34:57Z
dc.date.issued2021-06-08
dc.identifier.pmid34101127
dc.identifier.doi10.1007/s13346-021-01011-7
dc.identifier.urihttp://hdl.handle.net/10033/622919
dc.language.isoenen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAntibacterial nanoparticlesen_US
dc.subjectBenzothiazinoneen_US
dc.subjectDry powder formulationsen_US
dc.subjectLevofloxacinen_US
dc.subjectLiposomesen_US
dc.subjectRespiratory infectionsen_US
dc.subjectTuberculosisen_US
dc.titleSpray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals.en_US
dc.typeArticleen_US
dc.identifier.eissn2190-3948
dc.contributor.departmentHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.en_US
dc.identifier.journalDrug delivery and translational researchen_US
dc.source.volume11
dc.source.issue4
dc.source.beginpage1766
dc.source.endpage1778
refterms.dateFOA2021-07-01T13:34:57Z
dc.source.journaltitleDrug delivery and translational research
dc.source.countryUnited States


Files in this item

Thumbnail
Name:
Thiyagarajan et al.pdf
Size:
4.550Mb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International